Myasthenic Crisis: A Complete Nursing Guide to Recognition and Management

Introduction

Myasthenic crisis can develop within minutes to days, and about 1 in 5 people living with myasthenia gravis will face at least one episode. Because early recognition genuinely changes outcomes, nurses caring for MG patients need to know the subtle warning signs, not just the obvious ones. This guide covers how to recognize impending crisis, how it differs from a dangerous look-alike condition, and what nursing care actually looks like once treatment starts.

Table of Contents

1. What Is Myasthenic Crisis?
2. Triggers
3. Recognizing Impending Crisis
4. Myasthenic Crisis vs. Cholinergic Crisis
5. Nursing Respiratory Assessment
6. Treatment
7. Nursing Interventions
8. Medications to Avoid
9. Ventilator Weaning Considerations
10. NCLEX Tips and Memory Tricks
11. Clinical Pearls
12. Key Takeaways
13. FAQs
14. References

What Is Myasthenic Crisis?

Myasthenic crisis is a rare but life-threatening manifestation of myasthenia gravis, characterized by rapidly progressing weakness of the respiratory and bulbar muscles that can lead to severe dyspnea, respiratory insufficiency, and aspiration. Clinically, it’s defined as respiratory failure, or a need for mechanical ventilation lasting more than 24 hours after surgery, in a patient with MG. Because weakness can escalate from minutes to days, the window for early intervention is often narrower than clinicians expect.

Triggers

A precipitating factor can usually be identified in patients who develop myasthenic crisis. Common triggers include:

• Infection, which remains one of the most frequently identified triggers
• Surgery or anesthesia exposure
• Certain medications known to worsen MG (see below)
• Undertreatment — whether from poor adherence to the therapeutic regimen or inadequate dosing
• Emotional or physical stress
• Pregnancy or hormonal changes
• Rapid steroid tapering or initiation in some cases

Recognizing Impending Crisis

Prompt recognition of impending crisis may prevent progression to fulminant crisis. Watch for:

• Tachypnea — rapid, shallow breathing as the patient compensates for weakening respiratory muscles
• Weakening cough and difficulty clearing secretions
• New or worsening dysphagia
• Increasing fatigue with speech (dysarthria that worsens over a conversation)
• Difficulty holding the head up or increasing neck flexor weakness
• Subjective sense of breathlessness, even before objective numbers change significantly

Because these signs can develop gradually, trending them across a shift matters more than any single assessment.

Myasthenic Crisis vs. Cholinergic Crisis

This distinction is critical, since the treatments are essentially opposite:

	Myasthenic Crisis	Cholinergic Crisis
Cause	Too little acetylcholinesterase inhibitor medication (undertreatment) or disease exacerbation	Too much acetylcholinesterase inhibitor medication
Nursing action	Administer the missed dose or increase dosage per provider orders	Hold the medication; supportive/ventilatory care until it clears

Both presentations can cause severe muscle weakness and respiratory depression, which is exactly why distinguishing between them matters so much — treating one as if it were the other can worsen the patient’s condition.

Nursing Respiratory Assessment

• Bedside pulmonary function measurements — negative inspiratory force (NIF) and vital capacity — are the gold standard for tracking respiratory muscle strength in these patients, often more sensitive than oxygen saturation alone
• Frequent respiratory rate and effort assessment, watching specifically for a rising trend
• Assess swallowing and secretion management, since bulbar weakness raises aspiration risk
• Continuous pulse oximetry, understanding that desaturation can be a late finding in neuromuscular respiratory failure
• Keep suction and airway equipment readily available at the bedside

Treatment

• Plasma exchange (PLEX) and intravenous immunoglobulin (IVIG) are the mainstay short-term treatments for impending and manifest myasthenic crisis
• Expert consensus suggests PLEX may work more quickly, though clinical trial evidence shows the two are comparably effective; the choice often depends on patient comorbidities — PLEX isn’t used in sepsis, and IVIG is avoided in renal failure, hypercoagulable states, or immunoglobulin hypersensitivity
• Patients require admission to an ICU or step-down unit for close respiratory and bulbar monitoring
• Mechanical ventilation, invasive or noninvasive, is initiated when respiratory failure develops or is clearly imminent
• Identifying and treating the underlying trigger (such as infection) runs alongside crisis-specific treatment

Nursing Interventions

• Perform frequent, trended respiratory assessments rather than relying on any single measurement
• Administer PLEX or IVIG per protocol, monitoring for treatment-specific complications
• Maintain strict aspiration precautions given bulbar weakness
• Prepare for possible intubation proactively rather than waiting until the patient is in overt respiratory failure
• Coordinate closely with the multidisciplinary team — neurology, respiratory therapy, and critical care all play essential roles
• Provide emotional support and clear communication, since a rapid decline can be frightening for both patients and family members
• Once stabilized, anticipate that weaning from mechanical ventilation often takes longer than in other respiratory failure causes, since respiratory muscle recovery follows its own timeline

Medications to Avoid

Certain medication classes are known to worsen myasthenia gravis and should be used cautiously, if at all, in these patients:

• Aminoglycosides
• Fluoroquinolones
• Macrolides (such as erythromycin, clarithromycin, azithromycin)
• Telithromycin — associated with severe, sometimes fatal MG exacerbation, and should not be used
• Certain neuromuscular blocking agents used in anesthesia, which require special consideration in this population

Reviewing the full medication list for any hospitalized MG patient — not just during an acute crisis — is a genuine safety intervention nurses are well positioned to catch.

Ventilator Weaning Considerations

Most patients with myasthenic crisis experience an intermediate or prolonged weaning course rather than a quick extubation, and this holds true regardless of the age at which their myasthenia gravis first developed. Most patients can be extubated within one to two weeks, with only a minority requiring tracheostomy. Because of this, weaning efforts generally focus on gradual, supported liberation from the ventilator rather than early tracheostomy, and aggressive disease-directed treatment (like plasma exchange) can help facilitate earlier extubation.

NCLEX Tips and Memory Tricks

• Myasthenic crisis = too little medication. Cholinergic crisis = too much medication. This single distinction resolves most exam questions on the topic.
• Remember: NIF and vital capacity, not oxygen saturation, are the most sensitive bedside indicators of worsening respiratory muscle strength in neuromuscular disease.
• If a question describes worsening dysarthria, dysphagia, or neck weakness in an MG patient, think impending crisis, even before major respiratory numbers change.
• Mnemonic — “CRISIS”: Check respiratory trend (NIF/VC), Respiratory support ready, Identify the trigger, Swallowing/aspiration precautions, IVIG or PLEX per protocol, Steer clear of contraindicated drugs.

Clinical Pearls

• Oxygen saturation can look deceptively reassuring right up until a neuromuscular patient decompensates — NIF and vital capacity trends catch deterioration earlier.
• Telithromycin causing severe, sometimes fatal MG exacerbation is a genuinely high-stakes medication safety fact worth double-checking on every MG patient’s med list.
• Weaning from mechanical ventilation in myasthenic crisis typically takes longer than nurses might expect from other neuromuscular respiratory failure causes — don’t be alarmed if progress feels slower than anticipated.

Key Takeaways

• Myasthenic crisis causes rapidly progressing respiratory and bulbar weakness, and about 1 in 5 people with MG will experience it at least once.
• Distinguishing myasthenic crisis from cholinergic crisis is critical, since treatment approaches are essentially opposite.
• PLEX and IVIG are the mainstay treatments, alongside respiratory support and trigger identification.
• Certain medication classes (aminoglycosides, fluoroquinolones, macrolides, telithromycin) can worsen MG and warrant caution.

FAQs

What triggers a myasthenic crisis?
Infection is among the most common triggers, along with surgery, certain medications, undertreatment of MG, and physical or emotional stress.

What is the difference between myasthenic crisis and cholinergic crisis?
Myasthenic crisis results from too little acetylcholinesterase inhibitor medication or disease exacerbation; cholinergic crisis results from too much of that medication. Treatment approaches differ accordingly.

How is myasthenic crisis treated?
Plasma exchange or IVIG as short-term mainstay treatments, respiratory support up to mechanical ventilation as needed, ICU-level monitoring, and identification and treatment of the underlying trigger.

Which medications should be avoided in patients with myasthenia gravis?
Aminoglycosides, fluoroquinolones, macrolides, and telithromycin are all known to potentially worsen MG and should be used with caution or avoided.

What are the early warning signs of impending myasthenic crisis?
Tachypnea, a weakening cough, new or worsening difficulty swallowing, and increasing fatigue with speech or neck weakness — often developing before major respiratory numbers change.

References

• Neurology (AAN) — International Consensus Guidance for Management of Myasthenia Gravis
• Myasthenia Gravis Foundation of America — Emergency Management of Myasthenia Gravis: Information and Guidance
• EMCrit/IBCC — Myasthenia Gravis & Myasthenic Crisis
• NURSING.com — Nursing Care Plan (NCP) for Myasthenia Gravis (MG)